Annual Statements Open main menu

DIODES INC /DEL/ - Quarter Report: 2020 March (Form 10-Q)

4444wNN

29.9

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2020

Or

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from                      to                     .

Commission file number: 002-25577

 

DIODES INCORPORATED

(Exact name of registrant as specified in its charter)

 

 

Delaware

 

95-2039518

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification Number)

 

4949 Hedgcoxe Road, Suite 200, Plano, Texas

 

75024

(Address of principal executive offices)

 

(Zip code)

(972) 987-3900

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common Stock, Par Value $0.66 2/3

 

DIOD

 

The NASDAQ Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer

 

  

Accelerated filer

 

 

 

 

 

Non-accelerated filer

 

  

  

Smaller reporting company

 

 

 

 

 

 

 

 

Emerging growth company

 

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes       No  

The number of shares of the registrant’s Common Stock outstanding as of May 4, 2020 was 51,486,679.

 

 

 


 

Table of Contents

 

 

  

Page

 

Part I – Financial Information

  

 

 

Item 1. Financial Statements

  

3

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

  

21

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

  

32

 

Item 4. Controls and Procedures

  

32

 

Part II – Other Information

  

 

Item 1. Legal Proceedings

 

33

Item 1A. Risk Factors

 

33

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

34

Item 3. Defaults Upon Senior Securities

 

34

Item 4. Mine Safety Disclosures

 

34

Item 5. Other Information

 

34

Item 6. Exhibits

 

35

 

Signatures

  

36

 

 

 

 


PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

DIODES INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share data)

 

 

March 31,

 

 

December 31,

 

 

2020

 

 

2019

 

 

(Unaudited)

 

 

 

 

 

Assets

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash and cash equivalents

$

269,516

 

 

$

258,390

 

Short-term investments

 

2,859

 

 

 

4,825

 

Accounts receivable, net of allowances of $4,855 and $4,866 at

  March 31, 2020 and December 31, 2019, respectively

 

243,746

 

 

 

260,322

 

Inventories

 

232,184

 

 

 

236,472

 

Prepaid expenses and other

 

48,141

 

 

 

49,950

 

Total current assets

 

796,446

 

 

 

809,959

 

Property, plant and equipment, net

 

456,122

 

 

 

469,574

 

Deferred income tax

 

16,994

 

 

 

17,516

 

Goodwill

 

149,666

 

 

 

141,318

 

Intangible assets, net

 

121,218

 

 

 

119,523

 

Other long-term assets

 

79,820

 

 

 

81,494

 

Total assets

$

1,620,266

 

 

$

1,639,384

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Line of credit

$

13,397

 

 

$

13,342

 

Accounts payable

 

112,075

 

 

 

122,148

 

Accrued liabilities and other

 

88,327

 

 

 

100,571

 

Income tax payable

 

15,642

 

 

 

16,156

 

Current portion of long-term debt

 

34,676

 

 

 

33,105

 

Total current liabilities

 

264,117

 

 

 

285,322

 

Long-term debt, net of current portion

 

46,011

 

 

 

64,401

 

Deferred tax liabilities

 

16,348

 

 

 

16,333

 

Other long-term liabilities

 

111,501

 

 

 

120,545

 

Total liabilities

 

437,977

 

 

 

486,601

 

 

 

 

 

 

 

 

 

Commitments and contingencies (See Note 8)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders' equity

 

 

 

 

 

 

 

Preferred stock - par value $1.00 per share; 1,000,000 shares authorized; no

  shares issued or outstanding

 

-

 

 

 

-

 

Common stock - par value $0.66 2/3 per share; 70,000,000 shares

  authorized;  51,450,808 and 51,206,969, issued and outstanding

  at March 31, 2020  and December 31, 2019,  respectively

 

35,289

 

 

 

35,111

 

Additional paid-in capital

 

427,543

 

 

 

427,262

 

Retained earnings

 

810,126

 

 

 

789,958

 

Treasury stock at cost, 1,480,840 and 1,457,206, issued and outstanding at

  March 31, 2020 and December 31, 2019, respectively

 

(38,457

)

 

 

(37,768

)

Accumulated other comprehensive loss

 

(109,472

)

 

 

(108,139

)

Total stockholders' equity

 

1,125,029

 

 

 

1,106,424

 

Noncontrolling interest

 

57,260

 

 

 

46,359

 

Total equity

 

1,182,289

 

 

 

1,152,783

 

Total liabilities and stockholders' equity

$

1,620,266

 

 

$

1,639,384

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 

-3-


 

DIODES INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except per share data)

 

 

Three Months Ended

 

 

March 31,

 

 

2020

 

 

2019

 

Net sales

$

280,717

 

 

$

302,293

 

Cost of goods sold

 

184,875

 

 

 

189,882

 

Gross profit

 

95,842

 

 

 

112,411

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

Selling, general and administrative

 

42,215

 

 

 

43,688

 

Research and development

 

23,678

 

 

 

22,170

 

Amortization of acquisition related intangible assets

 

4,221

 

 

 

4,484

 

Other operating (income)

 

(124

)

 

 

(54

)

Total operating expense

 

69,990

 

 

 

70,288

 

 

 

 

 

 

 

 

 

Income from operations

 

25,852

 

 

 

42,123

 

 

 

 

 

 

 

 

 

Other income (expense)

 

 

 

 

 

 

 

Interest income

 

273

 

 

 

875

 

Interest expense

 

(1,245

)

 

 

(2,145

)

Foreign currency gain (loss), net

 

75

 

 

 

(64

)

Other income

 

1

 

 

 

1,245

 

Total other income (expense)

 

(896

)

 

 

(89

)

 

 

 

 

 

 

 

 

Income before income taxes and noncontrolling interest

 

24,956

 

 

 

42,034

 

Income tax provision

 

4,556

 

 

 

10,298

 

Net income

 

20,400

 

 

 

31,736

 

Less net (income) attributable to noncontrolling interest

 

(232

)

 

 

(20

)

Net income attributable to common stockholders

$

20,168

 

 

$

31,716

 

 

 

 

 

 

 

 

 

Earnings per share attributable to common stockholders:

 

 

 

 

 

 

 

Basic

$

0.39

 

 

$

0.63

 

Diluted

$

0.38

 

 

$

0.62

 

Number of shares used in earnings per share computation:

 

 

 

 

 

 

 

Basic

 

51,335

 

 

 

50,398

 

Diluted

 

52,422

 

 

 

51,462

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 

-4-


 

DIODES INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

(In thousands)

 

 

Three Months Ended

 

 

March 31,

 

 

2020

 

 

2019

 

Net income

$

20,400

 

 

$

31,736

 

Unrealized gain (loss) on defined benefit plan, net of tax

 

9,719

 

 

 

(6,029

)

Unrealized loss on swaps and collars, net of tax

 

(1,438

)

 

 

(3,909

)

Unrealized foreign currency (loss) gain, net of tax

 

(9,614

)

 

 

4,936

 

Comprehensive income

 

19,067

 

 

 

26,734

 

Less: Comprehensive income attributable to noncontrolling interest

 

(232

)

 

 

(20

)

Total comprehensive income attributable to common stockholders

$

18,835

 

 

$

26,714

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 


-5-


 

DIODES INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY

(Unaudited)

(In thousands)

 

 

 

Common stock

 

 

Treasury stock

 

 

Additional

paid-in

 

 

Retained

 

 

Accumulated

other comprehensive

 

 

Total Diodes

Incorporated Stockholders'

 

 

Noncontrolling

 

 

Total

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

capital

 

 

earnings

 

 

loss

 

 

equity

 

 

interest

 

 

equity

 

Balance, December 31, 2018

 

 

51,678

 

 

$

34,454

 

 

 

(1,457

)

 

$

(37,768

)

 

$

399,915

 

 

$

636,708

 

 

$

(101,846

)

 

$

931,463

 

 

$

45,969

 

 

$

977,432

 

Total comprehensive income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

31,716

 

 

 

(5,002

)

 

 

26,714

 

 

 

20

 

 

 

26,734

 

Noncontrolling interests

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,755

 

 

 

2,755

 

Dividends to noncontrolling interest

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(121

)

 

 

(121

)

Common stock issued for share-based plans

 

 

376

 

 

 

250

 

 

 

-

 

 

 

-

 

 

 

6,417

 

 

 

-

 

 

 

-

 

 

 

6,667

 

 

 

-

 

 

 

6,667

 

Share-based compensation

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

4,476

 

 

 

-

 

 

 

-

 

 

 

4,476

 

 

 

-

 

 

 

4,476

 

Tax related to net share settlement

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(645

)

 

 

-

 

 

 

-

 

 

 

(645

)

 

 

-

 

 

 

(645

)

Balance, March 31, 2019

 

 

52,054

 

 

$

34,704

 

 

 

(1,457

)

 

$

(37,768

)

 

$

410,163

 

 

$

668,424

 

 

$

(106,848

)

 

$

968,675

 

 

$

48,623

 

 

$

1,017,298

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, December 31, 2019

 

 

52,664

 

 

$

35,111

 

 

 

(1,457

)

 

$

(37,768

)

 

$

427,262

 

 

$

789,958

 

 

$

(108,139

)

 

$

1,106,424

 

 

$

46,359

 

 

$

1,152,783

 

Total comprehensive income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

20,168

 

 

 

(1,333

)

 

 

18,835

 

 

 

232

 

 

 

19,067

 

Contributions from noncontrolling interests

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

10,777

 

 

 

10,777

 

Dividends to noncontrolling interest

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(108

)

 

 

(108

)

Common stock issued for share-based plans

 

 

268

 

 

 

178

 

 

 

-

 

 

 

-

 

 

 

(178

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Share-based compensation

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

4,237

 

 

 

-

 

 

 

-

 

 

 

4,237

 

 

 

-

 

 

 

4,237

 

Deferred compensation plan

 

 

-

 

 

 

-

 

 

 

(24

)

 

 

(689

)

 

 

689

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Tax related to net share settlement

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(4,467

)

 

 

-

 

 

 

-

 

 

 

(4,467

)

 

 

-

 

 

 

(4,467

)

Balance,  March 31, 2020

 

 

52,932

 

 

$

35,289

 

 

 

(1,481

)

 

$

(38,457

)

 

$

427,543

 

 

$

810,126

 

 

$

(109,472

)

 

$

1,125,029

 

 

$

57,260

 

 

$

1,182,289

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 

-6-


 

DIODES INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

 

 

Three Months Ended

 

 

March 31,

 

 

2020

 

 

2019

 

Operating Activities

 

 

 

 

 

 

 

Net income

$

20,400

 

 

$

31,736

 

Adjustments to reconcile net income to net cash provided by operating activities, net of effects of acquisitions

 

 

 

 

 

 

 

Depreciation

 

22,809

 

 

 

22,157

 

Amortization of intangible assets

 

4,221

 

 

 

4,484

 

Share-based compensation expense

 

4,693

 

 

 

4,476

 

Deferred income taxes

 

17

 

 

 

31

 

Other

 

741

 

 

 

(221

)

Changes in operating assets:

 

 

 

 

 

 

 

Change in accounts receivable

 

16,139

 

 

 

12,874

 

Change in inventory

 

2,550

 

 

 

(200

)

Change in other operating assets

 

(1,022

)

 

 

2,605

 

Changes in operating liabilities:

 

 

 

 

 

 

 

Change in accounts payable

 

(9,160

)

 

 

(11,201

)

Change in accrued liabilities

 

(12,105

)

 

 

(4,874

)

Change in income tax payable

 

3,853

 

 

 

5,678

 

Change in other operating liabilities

 

539

 

 

 

2,344

 

Net cash flows provided by operating activities

 

53,675

 

 

 

69,889

 

 

 

 

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

 

 

 

Acquisitions, net of cash received

 

591

 

 

 

-

 

Purchases of property, plant and equipment

 

(14,208

)

 

 

(18,639

)

Purchases of short-term investments

 

(1,523

)

 

 

(3,153

)

Purchase of equity securities

 

(6,129

)

 

 

-

 

Proceeds from maturity of short-term investments

 

3,467

 

 

 

3,982

 

Other

 

244

 

 

 

658

 

Net cash and cash equivalents used in investing activities

 

(17,558

)

 

 

(17,152

)

 

 

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

 

 

Advances on lines of credit and short-term debt

 

3,647

 

 

 

3,568

 

Repayments of line of credit and short-term debt

 

(3,498

)

 

 

(1,461

)

Taxes paid related to net share settlement

 

(4,467

)

 

 

(645

)

Proceeds from long-term debt

 

82,331

 

 

 

85,000

 

Repayments of long-term debt

 

(98,884

)

 

 

(83,089

)

Net proceeds from issuance of common stock

 

-

 

 

 

6,667

 

Repayment of and proceeds from finance lease obligation

 

(223

)

 

 

(293

)

Dividend distribution to noncontrolling interests

 

(108

)

 

 

-

 

Other

 

(195

)

 

 

(120

)

Net cash and cash equivalents (used in) provided by financing activities

 

(21,397

)

 

 

9,627

 

 

 

 

 

 

 

 

 

Effect of exchange rate changes on cash and cash equivalents

 

(3,315

)

 

 

(1,890

)

Change in cash and cash equivalents, including restricted cash

 

11,405

 

 

 

60,474

 

Cash and cash equivalents, beginning of period, including restricted cash

 

259,507

 

 

 

241,833

 

Cash and cash equivalents, end of period, including restricted cash

 

270,912

 

 

$

302,307

 

 


-7-


 

Supplemental Cash Flow Information

 

 

 

 

 

 

 

Interest paid during the period

 

1,068

 

 

$

2,095

 

Taxes paid during the period

 

6,091

 

 

$

4,323

 

Non-cash investing and financing activities:

 

 

 

 

 

 

 

Accounts payable balance related to the purchase of

   property, plant and equipment

$

8,847

 

 

$

9,886

 

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets to the total of the same such amounts shown above:

 

 

Three Months Ended

 

March 31,

 

2020

 

2019

Current assets:

 

 

 

Cash and cash equivalents

$269,516

 

$301,167

Restricted cash (included in other current assets)

1,396

 

1,140

Total cash, cash equivalents and restricted cash

$270,912

 

$302,307

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

-8-


 

DIODES INCORPORATED AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 1 – Summary of Operations and Significant Accounting Policies

Summary of Operations

Diodes Incorporated, together with its subsidiaries (collectively, the “Company,” “we” or “our”) (Nasdaq: DIOD), is a leading global manufacturer and supplier of high-quality, application-specific standard products within the broad discrete, logic, analog and mixed-signal semiconductor markets. We serve the consumer electronics, computing, communications, industrial, and automotive markets. Our products include diodes, rectifiers, transistors, MOSFETs, protection devices, function-specific arrays, single gate logic, amplifiers and comparators, Hall-effect and temperature sensors, power management devices, including LED drivers, AC-DC converters and controllers, DC-DC switching and linear voltage regulators, and voltage references along with special function devices, such as USB power switches, load switches, voltage supervisors, and motor controllers. We also have timing, connectivity, switching, and signal integrity solutions for high-speed signals. Our corporate headquarters and Americas’ sales offices are located in Plano, Texas and Milpitas, California. Design, marketing, and engineering centers are located in Plano; Milpitas; Taipei, Taoyuan City and Zhubei City, Taiwan; Oldham, England; and Neuhaus, Germany. Our wafer fabrication facilities are located in Oldham and Shanghai, China and Greenock, Scotland. We have assembly and test facilities located in Shanghai, Jinan and Chengdu, China, as well as in Hong Kong, Neuhaus and Taipei. Additional engineering, research and development, sales, warehouse, and logistics offices are located in Taipei; Hong Kong; Oldham; Shanghai; Shenzhen and Yangzhou, China; Seongnam-si, South Korea; Munich, Germany; and Tokyo, Japan, with support offices throughout the world.

Basis of Presentation

The condensed consolidated financial data at December 31, 2019 is derived from audited financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2019 filed with the Securities and Exchange Commission (“SEC”) on February 12, 2020 (“Form 10-K”). The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States Generally Accepted Accounting Principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q. They do not include all information and footnotes necessary for a fair presentation of financial position, operating results and cash flows in conformity with GAAP for complete financial statements. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes contained in our Form 10-K.  All significant intercompany balances and transactions have been eliminated in consolidation. In the opinion of management, all adjustments (consisting of normal recurring adjustments and accruals) considered necessary for a fair presentation of the operating results for the period presented have been included in the interim period. Operating results for the three months ended March 31, 2020 are not necessarily indicative of the results that may be expected for other interim periods or the year ending December 31, 2020.

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates. As permitted under GAAP, interim accounting for certain expenses, including income taxes, are based on full year forecasts. For interim financial reporting purposes, income taxes are recorded based upon estimated annual effective income tax rates taking into consideration discrete items occurring in a quarter.

Dollar amounts and share amounts are presented in thousands, except per share amounts, unless otherwise noted. Certain prior year’s balances may have been reclassified to conform to the current financial statement presentation.

Recently Issued Accounting Pronouncements

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, which requires measurement and recognition of expected credit losses for financial assets held. We adopted ASU No. 2016-13 effective January 1, 2020. The adoption of ASU No 2016-13 did not have a material impact on our consolidated financial statements and related disclosures.

In March 2020, the FASB issued optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The guidance is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact that this guidance will have on its financial statements and related disclosures.

-9-


 

NOTE 2 – Earnings per Share

Earnings per share (“EPS”) is calculated by dividing net income attributable to common stockholders by the weighted-average number of shares of Common Stock outstanding during the period. Diluted EPS is calculated similarly but includes potential dilution from the exercise of stock options and stock awards, except when the effect would be anti-dilutive.  During the three months ended March 31, 2020 and 2019 we paid no dividends on our Common Stock.

The table below sets forth the reconciliation between net income and the weighted average shares outstanding used for calculating basic and diluted EPS:

 

 

Three Months Ended

 

 

March 31,

 

 

2020

 

 

2019

 

Earnings (numerator)

 

 

 

 

 

 

 

Net income attributable to common stockholders

$

20,168

 

 

$

31,716

 

 

 

 

 

 

 

 

 

Shares (denominator)

 

 

 

 

 

 

 

Weighted average common shares outstanding (basic)

 

51,335

 

 

 

50,398

 

Dilutive effect of stock options and stock awards outstanding

 

1,087

 

 

 

1,064

 

Adjusted weighted average common shares outstanding (diluted)

 

52,422

 

 

 

51,462

 

 

 

 

 

 

 

 

 

Earnings per share attributable to common stockholders

 

 

 

 

 

 

 

Basic

$

0.39

 

 

$

0.63

 

Diluted

$

0.38

 

 

$

0.62

 

 

 

 

 

 

 

 

 

Stock options and stock awards excluded from EPS

  calculation because the effect would be anti-dilutive

 

58

 

 

 

58

 

 

NOTE 3 – Inventories

The table below sets forth inventories which are stated at the lower of cost or net realizable value:

 

 

March 31, 2020

 

 

December 31, 2019

 

Finished goods

$

53,747

 

 

$

62,900

 

Work-in-progress

 

48,684

 

 

 

55,082

 

Raw materials

 

129,753

 

 

 

118,490

 

Total

$

232,184

 

 

$

236,472

 

 

 

NOTE 4 – Goodwill and Intangible Assets

The table below sets forth the changes in goodwill:

 

Balance at December 31, 2019

$

141,318

 

Savitech acquisition (see Note 13 for additional information)

 

10,755

 

Foreign currency translation adjustment

 

(2,407

)

Balance at March 31, 2020

$

149,666

 

 

-10-


 

The table below sets forth the value of intangible assets, other than goodwill:

 

 

 

March 31,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Intangible assets subject to amortization:

 

 

 

 

 

 

 

 

Gross carrying amount

 

$

248,897

 

 

$

239,975

 

Accumulated amortization

 

 

(128,672

)

 

 

(124,452

)

Foreign currency translation adjustment

 

 

(8,247

)

 

 

(9,842

)

Total

 

 

111,978

 

 

 

105,681

 

Intangible assets with indefinite lives:

 

 

 

 

 

 

 

 

Gross carrying amount

 

 

10,412

 

 

 

14,883

 

Foreign currency translation adjustment

 

 

(1,172

)

 

 

(1,041

)

Total

 

 

9,240

 

 

 

13,842

 

Total intangible assets, net

 

$

121,218

 

 

$

119,523

 

 

The table below sets forth amortization expense related to intangible assets subject to amortization:

 

Amortization expense

 

2020

 

 

2019

 

Three months ended March 31

 

$

4,221

 

 

$

4,484

 

 

NOTE 5 – Income Tax Provision

 

The table below sets forth information related to our income tax expense:

 

 

Three Months Ended

 

 

March 31,

 

 

2020

 

 

2019

 

Domestic pre-tax income

$

5,268

 

 

$

12,486

 

Foreign pre-tax income

$

19,688

 

 

$

29,548

 

Income tax provision

$

4,556

 

 

$

10,298

 

Effective tax rate

 

18.3

%

 

 

24.5

%

Impact of tax holidays on tax expense

$

(1,074

)

 

$

277

 

Earnings per share impact of tax holidays:

 

 

 

 

 

 

 

Basic

$

0.02

 

 

$

(0.01

)

Diluted

$

0.02

 

 

$

(0.01

)

 

The decrease in the effective tax rate for the three months ended March 31, 2020 when compared to the three months ended March 31, 2019, is primarily attributable to a decrease in non-U.S. withholding taxes and a net increase in favorable U.S. permanent differences.         

Our undistributed foreign earnings continue to be indefinitely reinvested in foreign operations, with limited exceptions related to earnings of certain European and Asian subsidiaries.  Any future distributions of foreign earnings will not be subject to additional U.S. income tax, but may be subject to non-U.S. withholding taxes.

We file income tax returns in the U.S. federal jurisdiction and in various state and foreign jurisdictions. We are no longer subject to U.S. federal income tax examinations by tax authorities for tax years before 2012, or for the 2015 tax year. We are no longer subject to China income tax examinations by tax authorities for tax years before 2009. With respect to state and local jurisdictions and countries outside of the U.S. (other than China), with limited exceptions, the Company is no longer subject to income tax audits for years before 2014. Although the outcome of tax audits is always uncertain, the Company believes that adequate amounts of tax, interest and penalties, if any, have been provided for in the Company’s reserve for any adjustments that may result from currently pending tax audits. The Company recognizes accrued interest and penalties related to unrecognized tax benefits in interest expense.  As of March 31, 2020, the gross amount of unrecognized tax benefits was approximately $38.4 million. 

-11-


 

It is reasonably possible that the amount of the unrecognized benefit with respect to certain of the Company’s unrecognized tax positions will significantly increase or decrease within the next 12 months. At this time, an estimate of the range of the reasonably possible outcomes cannot be made.

In response to the outbreak of the novel strain of coronavirus (“COVID-19”) pandemic, the United States Coronavirus Aid, Relief, and Economic Security (“CARES”) Act was enacted on March 27, 2020.  We do not expect the CARES Act to have a material impact on our financial statements because we do not qualify for most of the relief provisions prescribed in the Cares Act. We will continue to assess the impacts of the CARES Act and any other legislation adopted by the United States government or other applicable governmental agencies in response to COVID-19 as additional guidance is published by the relevant authorities.

NOTE 6 – Share-Based Compensation

All share-based compensation is for share grants.  All outstanding stock options are fully vested, and all expense related to stock options has been recognized in previous periods. No cash proceeds were received from stock option exercises during the three months ended March 31, 2020. The table below sets forth the line items where share-based compensation expense was recorded:

 

 

Three Months Ended

 

 

March 31,

 

 

2020

 

 

2019

 

Cost of goods sold

$

273

 

 

$

125

 

Selling, general and administrative

 

3,711

 

 

 

3,637

 

Research and development

 

709

 

 

 

715

 

Total share-based compensation expense

$

4,693

 

 

$

4,477

 

 

Share Grants – Restricted stock awards and restricted stock units generally vest in equal annual installments over a four-year period. All new grants are granted under the Company’s 2013 Equity Incentive Plan, and there will be no additional share grants under the 2001 Omnibus Equity Incentive Plan. Restricted stock grants are measured based on the fair market value of the underlying stock on the date of grant, and compensation expense is recognized on a straight-line basis over the requisite four-year service period.  

 

Performance stock units (“PSUs”) are measured based on the fair market value of the underlying stock on the date of grant and compensation expense is recognized over the three-year performance period, with adjustments made to the expense to recognize the probable payout percentage. PSUs will vest upon the Company achieving a cumulative 3-year non-GAAP operating income target for the applicable periods.

As of March 31, 2020, total unrecognized share-based compensation expense related to share grants was approximately $45.4 million, before income taxes, and is expected to be recognized over a weighted average period of approximately 2.2 years.          

NOTE 7 – Segment Information and Net Sales

Segment Reporting. For financial reporting purposes, we operate in a single segment, standard semiconductor products, through our various manufacturing and distribution facilities. We aggregate our products because the products are similar and have similar economic characteristics, use similar production processes and share the same customer type. Our primary operations include operations in Asia, North America and Europe.  During the three months ended March 31, 2020 and 2019, no customer accounted for 10% or more of our revenue. No customer accounted for 10% or more of our outstanding accounts receivable at any point in the periods presented in this report.  

 

-12-


 

The tables below set forth net sales based on the location of the subsidiary producing the net sale.

 

As of and for the

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31, 2020

 

Asia

 

 

North America

 

 

Europe

 

 

Consolidated

 

Total sales

 

$

301,863

 

 

$

168,172

 

 

$

59,001

 

 

$

529,036

 

Intercompany elimination

 

 

(116,921

)

 

 

(104,464

)

 

 

(26,934

)

 

 

(248,319

)

Net sales

 

$

184,942

 

 

$

63,708

 

 

$

32,067

 

 

$

280,717

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Property, plant and equipment, net

 

$

364,624

 

 

$

24,110

 

 

$

67,388

 

 

$

456,122

 

Total assets

 

 

1,208,572

 

 

 

197,178

 

 

 

214,516

 

 

$

1,620,266

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of and for the

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31, 2019

 

Asia

 

 

North America

 

 

Europe

 

 

Consolidated

 

Total sales

 

$

273,900

 

 

$

101,280

 

 

$

51,052

 

 

$

426,232

 

Intercompany elimination

 

 

(73,597

)

 

 

(37,916

)

 

 

(12,426

)

 

 

(123,939

)

Net sales

 

$

200,303

 

 

$

63,364

 

 

$

38,626

 

 

$

302,293

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Property, plant and equipment, net

 

$

387,264

 

 

$

28,402

 

 

$

25,549

 

 

$

441,215

 

Total assets

 

$

1,163,989

 

 

$

222,696

 

 

$

226,313

 

 

$

1,612,998

 

 

Disaggregation of Net Sales. We disaggregate net sales from contracts with customers into direct sales and distribution sales (“Distributors”) and by geographic area. Direct sales customers consist of those customers using our product in their manufacturing process, and Distributors are those customers who resell our products to third parties. We deliver our products to customers around the world for use in consumer electronics, computing, communications, industrial and automotive. Further, most of our contracts are fixed-price arrangements, and are short term in nature, ranging from days to several months.

The tables below set forth revenue for the Company disaggregated into geographic locations based on shipment and by type (direct sales or Distributor) for the three months ended March 31, 2020 and 2019:

 

 

 

Three Months Ended

Net Sales by Region

 

March 31, 2020

 

 

March 31, 2019

 

 

Asia

 

$

210,805

 

 

$

224,289

 

 

Europe

 

 

46,931

 

 

 

38,394

 

 

Americas

 

 

22,981

 

 

 

39,610

 

 

Total net sales

 

$

280,717

 

 

$

302,293

 

 

 

 

 

 

 

 

 

 

 

 

Net Sales by Type

 

 

 

 

 

 

 

 

 

Direct sales

 

$

99,544

 

 

$

86,358

 

 

Distributor sales

 

 

181,173

 

 

 

215,935

 

 

Total net sales

 

$

280,717

 

 

$

302,293

 

 

 

Revenue from products shipped to China was $138.9 million and $151.5 million for the three months ended March 31, 2020 and 2019, respectively.      

 

 

-13-


 

NOTE 8 – Commitments and Contingencies

Purchase commitments – As of March 31, 2020, we had approximately $38.7 million in non-cancelable purchase contracts related to capital expenditures, primarily related to our manufacturing facilities in Asia.  As of March 31, 2020, we also had a commitment to purchase approximately $52.5 million of wafers to be used in our manufacturing process.  These wafer purchases will occur during 2020.

Defined Benefit Plan - We have a contributory defined benefit plan that covers certain employees in the United Kingdom.  As of March 31, 2020, the unfunded liability for this defined benefit plan was approximately $14.0 million.  We are obligated to make annual contributions, each year through December 2029, of approximately GBP 2 million (approximately $2.4  million based on a GBP: USD exchange rate of 1.2:1).  The current annual contributions were set with regard to the funding position as of April 2016, and must be reviewed by the Trustees at least every three years. A review as of April 2019 is underway and the outcome of the review could result in a change in the amount of the payment or the period over which payment is required.

 

Contingencies – From time to time, we are involved in various legal proceedings that arise in the normal course of business. While we intend to defend any lawsuit vigorously, we presently believe that the ultimate outcome of any pending legal proceeding will not have any material adverse effect on our consolidated financial position, cash flows or operating results. However, litigation is subject to inherent uncertainties, and unfavorable rulings could occur. An unfavorable ruling could include monetary damages, which could impact our business and operating results for the period in which the ruling occurs or future periods.  Based on information available, we evaluate the likelihood of potential outcomes of all pending disputes. We record an appropriate liability when the amount of any liability associated with a pending dispute is deemed probable and reasonably estimable. In addition, we do not accrue for estimated legal fees and other directly related costs as they are expensed as incurred.  The Company is not currently a party to any pending litigation that the Company considers material.

 

 

Note 9 – Derivative Financial Instruments

 

We use derivative instruments to manage risks related to foreign currencies, interest rates and the net investment risk in our foreign subsidiaries. Our objectives for holding derivatives include reducing, eliminating, and efficiently managing the economic impact of these exposures as effectively as possible. Our derivative programs include strategies that both qualify and do not qualify for hedge accounting treatment.

Hedges of Foreign Currency Risk - We are exposed to fluctuations in various foreign currencies against our different functional currencies. We use foreign currency forward agreements to manage this exposure. At March 31, 2020, we had outstanding foreign currency forward contracts that are intended to preserve the economic value of foreign currency denominated monetary assets and liabilities; these instruments are not designated for hedge accounting treatment in accordance with ASC 815.  The fair value of these instruments approximates zero. 

-14-


 

The table below sets forth outstanding foreign currency forward contracts at March 31, 2020 and December 31, 2019:

 

Notional Amount

 

 

Effective Date

 

Maturity Date

 

Index*

Weighted Average Foreign Exchange Rate

 

 

Balance Sheet Hedge Designation

$

2,961

 

 

March 2020

 

May 2020

 

EUR/GBP

0.8848

 

 

Non-designated

 

4,009

 

 

March 2020

 

May 2020

 

EUR/USD

 

1.1009

 

 

Non-designated

 

10,445

 

 

March 2020

 

May 2020

 

GBP/USD

 

1.2453

 

 

Non-designated

 

37,850

 

 

March 2020

 

May 2020

 

USD/CNY

 

7.1036

 

 

Non-designated

 

1,136

 

 

March 2020

 

May 2020

 

USD/JPY

 

107.2520

 

 

Non-designated

 

42,028

 

 

March 2020

 

May 2020

 

USD/TWD

 

29.9560

 

 

Non-designated

 

500

 

 

January 2020

 

July 2020

 

USD/TWD

30

 

 

Non-designated

 

500

 

 

January 2020

 

January 2021

 

USD/TWD

29.976

 

 

Non-designated

 

500

 

 

March 2020

 

May 2020

 

USD/TWD

30.355

 

 

Non-designated

$

99,929

 

 

 

 

 

 

 

 

 

 

 

 

Notional Amount

 

 

Effective Date

 

Maturity Date

 

Index*

Weighted Average Foreign Exchange Rate

 

 

Balance Sheet Hedge Designation

$

1,844

 

 

December 2019

 

February 2020

 

EUR/GBP

0.8471

 

 

Non-designated

 

3,375

 

 

December 2019

 

February 2020

 

EUR/USD

1.123

 

 

Non-designated

 

25,957

 

 

December 2019

 

February 2020

 

GBP/USD

1.3257

 

 

Non-designated

 

39,340

 

 

December 2019

 

February 2020

 

USD/CNY

6.9762

 

 

Non-designated

 

763

 

 

December 2019

 

February 2020

 

USD/JPY

108.732

 

 

Non-designated

 

33,621

 

 

December 2019

 

February 2020

 

USD/TWD

20.988

 

 

Non-designated

 

500

 

 

January 2019

 

January 2020

 

USD/TWD

30.635

 

 

Non-designated

 

500

 

 

October 2019

 

February 2020

 

USD/TWD

30.571

 

 

Non-designated

$

105,900

 

 

 

 

 

 

 

 

 

 

 

 

*  EUR = Euro

 

 

 

 

 

 

 

 

 

    GBP = British Pound Sterling

 

 

 

 

 

 

 

 

 

    USD = United States Dollar

 

 

 

 

 

 

 

    CNY = Chinese Yuan Renminbi

 

 

 

 

 

 

 

    JPY =  Japan Yen

 

 

 

 

 

 

 

 

 

    TWD = Taiwan dollar

 

 

 

 

 

 

 

 

 

Hedges of Interest Rate and Net Investment Risk -The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish these objectives, the Company primarily uses interest rate swaps, including interest rate collars, as part of its interest rate risk management strategy.  Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. The table below sets forth information related to the number and the notional amount of our interest rate related derivative instruments at March 31, 2020 and December 31, 2019:

 

 

 

Number of Instruments

 

Notional Amount

 

 

 

2020

 

2019

 

2020

 

 

2019

 

Interest rate swaps and collars

 

9

 

9

 

$

175,000

 

 

$

200,000

 

 

-15-


 

The table below sets forth the fair value of the Company’s interest rate related derivative financial instruments as well as their classification on our condensed consolidated balance sheets as of March 31, 2020 and December 31, 2019:

 

 

 

Other Current Assets

 

 

Other Assets

 

 

Other Current Liabilities

 

 

Other Liabilities

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Interest rate swaps and collars

 

$

-

 

 

$

194

 

 

$

-

 

 

$

36

 

 

$

1,936

 

 

$

51

 

 

$

1,154

 

 

$

127

 

 

The tables below set forth the effect of the Company’s derivative financial instruments on our condensed consolidated statements of income for the three months ended March 31, 2020 and 2019:

 

 

 

Amount of Gain or (Loss) Recognized in OCI on Derivative

 

 

Location of Gain or (Loss) Reclassified from Accumulated OCI into

Income

 

Amount of Gain or (Loss) Reclassified from Accumulated OCI into Net Income

 

 

Location of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion  Excluded from Effectiveness Testing)

 

Amount of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion and Amount Excluded from Effectiveness Testing)

 

Derivative Instruments Designated as Hedging Instruments  

 

 

 

 

 

 

 

 

 

March 31,

 

 

 

March 31,

 

 

 

March 31,

 

 

2020

 

 

2019

 

 

 

2020

 

 

2019

 

 

 

2020

 

 

2019

 

Three Months Ended

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaps and collars

 

$

(1,390

)

 

$

(1,090

)

 

Interest expense

 

$

(71

)

 

$

(469

)

 

Interest expense

 

$

-

 

 

$

-

 

Cross currency swaps

 

$

-

 

 

$

(2,350

)

 

N/A

 

$

-

 

 

$

-

 

 

Interest income

 

$

-

 

 

$

455

 

 

We estimate that $0.6 million of net derivative gains included in accumulated other comprehensive income (“AOCI”) as of March 31, 2020 will be reclassified into expense within the following 12 months. No gains or losses were reclassified from AOCI into earnings as a result of forecasted transactions that failed to occur during three months ended March 31, 2020 or 2019.

 

 

 

 

 

 

 

Amount of (Loss) or Gain Recognized in Net Income

 

 

Location of Gain or (Loss) Recognized in Net Income

 

Derivative Instruments Not Designated as Hedging Instruments

 

 

 

 

March 31,

 

 

2020

 

 

2019

 

 

Three Months Ended

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts

 

$

(2,147

)

 

$

430

 

 

Foreign currency loss, net

 

As of March 31, 2020 and December 31, 2019, the Company had not posted any collateral related to these agreements.

 

 

-16-


 

NOTE 10 – Leases

The Company leases certain assets used in its business, including land, buildings and equipment.  These leased assets are used for operational and administrative purposes.

The components of lease expense are set forth in the table below:

 

 

 

Three Months Ended

 

Three Months Ended

 

 

March 31, 2020

 

March 31, 2019

Operating lease expense

 

$

3,730

 

$

3,704

Finance lease expense:

 

 

 

 

 

 

Amortization of assets

 

 

209

 

 

244

Interest on lease liabilities

 

 

7

 

 

15

Short-term lease expense

 

 

94

 

 

36

Variable lease expense

 

 

711

 

 

618

Total lease expense

 

$

4,751

 

$

4,617

 

The table below sets forth supplemental balance sheet information related to leases:

 

 

 

March 31, 2020

 

December 31, 2019

Operating leases:

 

 

 

 

Operating lease ROU assets

 

$53,933

 

$57,427

 

 

 

 

 

Current operating lease liabilities

 

11,633

 

12,554

Noncurrent operating lease liabilities

 

24,713

 

27,545

Total operating lease liabilities

 

$36,346

 

$40,099

 

 

 

 

 

Finance leases:

 

 

 

 

Finance lease ROU assets

 

$2,507

 

$3,396

Accumulated amortization

 

(1,671)

 

(1,924)

Finance lease ROU assets, net

 

$836

 

$1,472

 

 

 

 

 

Current finance lease liabilities

 

$818

 

$903

Non-current finance lease liabilities

 

 

138

Total finance lease liabilities

 

$818

 

$1,041

 

 

 

 

 

Weighted average remaining lease term (in years):

 

 

 

 

Operating leases

 

4.3

 

4.4

Finance leases

 

1.0

 

1.3

 

 

 

 

 

Weighted average discount rate:

 

 

 

 

Operating leases

 

3.8%

 

3.8%

Finance leases

 

3.0%

 

3.0%

 

 

The table below sets forth supplemental cash flow and other information related to leases:

 

 

 

Three Months Ended

 

Three Months Ended

 

 

March 31, 2020

 

March 31, 2019

Cash paid for the amounts included in the measurements of lease liabilities:

 

 

 

 

Operating cash outflows from operating leases

 

$4,018

 

$4,277

Operating cash outflows from finance leases

 

7

 

15

Financing cash outflow from finance leases

 

223

 

293

 

 

 

 

 

ROU assets obtained in exchange for lease liabilities incurred:

 

 

 

 

Operating leases

 

127

 

86

-17-


 

 

The table below sets forth information about lease liability maturities:

 

 

 

March 31, 2020

 

 

Operating Leases

 

Finance Leases

Remainder of 2020

 

$

10,129

 

$

691

2021

 

 

9,674

 

 

139

2022

 

 

8,000

 

 

-

2023

 

 

4,452

 

 

-

2024

 

 

2,379

 

 

-

2025

 

 

2,286

 

 

-

2026 and thereafter

 

 

2,579

 

-

Total lease payments

 

 

39,499

 

 

830

Less: imputed interest

 

 

(3,153)

 

 

(12)

Total lease obligations

 

 

36,346

 

 

818

Less: current obligations

 

 

(11,633)

 

 

(818)

Long-term lease obligations

 

$

24,713

 

$

-

 

 

NOTE 11 – Employee Benefit Plans  

We maintain a Non-Qualified Deferred Compensation Plan (the “Deferred Compensation Plan”) for executive officers, key employees and members of the Board of Directors. The Deferred Compensation Plan allows eligible participants to defer the receipt of eligible compensation, including equity awards, until designated future dates. We offset our obligations under the Deferred Compensation Plan primarily by investing in the actual underlying investments. At March 31, 2020 and December 31, 2019, these investments totaled approximately $10.0 million and $12.9 million, respectively.

NOTE 12 Related Parties

We conduct business with a related party company, Lite-On Semiconductor Corporation and its subsidiaries and affiliates (collectively, “LSC”), and Nuvoton Technology Corporation and its subsidiaries and affiliates (collectively, “Nuvoton”). LSC is our largest stockholder, owning approximately 15% of our outstanding Common Stock as of March 31, 2020, and is a member of the Lite-On Group of companies. On August 8, 2019, we announced that we entered into an agreement with LSC pursuant to which the Company shall acquire LSC. The aggregate consideration payable by the Company, based on the December 31, 2019 exchange rate, is approximately $437 million. This amount is subject to change, based on the Taiwan dollar to United States dollar exchange rate at closing. The acquisition received LSC stockholder approval on October 25, 2019, and we anticipate completing the acquisition in the second half of 2020, subject to customary closing conditions and regulatory approvals.  We expect to fund the purchase price of the transaction primarily with proceeds from an anticipated new bank financing arrangement.  Raymond Soong, the Chairman of our Board of Directors, is the Chairman of LSC, and is the Chairman of Lite-On Technology Corporation (“LTC”), a significant shareholder of LSC. C.H. Chen, our former President and Chief Executive Officer and currently the Vice Chairman of our Board of Directors, is also Vice Chairman of LSC and a board member of LTC. Dr. Keh-Shew Lu, our President and Chief Executive Officer and a member of our Board of Directors, is a board member of LTC, and a board member of Nuvoton. We consider our relationships with LSC and Nuvoton to be mutually beneficial, and we plan to continue our strategic alliance with LSC and Nuvoton.  We purchase wafers from Nuvoton for use in our production process.

We also conduct business with Keylink International (B.V.I.) Inc. and its subsidiaries and affiliates (collectively, “Keylink”). Keylink is our 5% joint venture partner in our Shanghai assembly and test facilities.  We sell products to, and purchase inventory from Keylink. In addition, our subsidiaries in China lease their manufacturing facilities in Shanghai from, and subcontract a portion of our manufacturing process (metal plating and environmental services) to, Keylink. We also pay fees for plating and rental services and consulting to Keylink. The aggregate amounts paid to Keylink for the three months ended March 31, 2020 and 2019 were approximately $3.1 million and $3.9 million, respectively. In addition, Chengdu Ya Guang Electronic Company Limited (“Ya Guang”) is our 2% joint venture partner in one of our Chengdu assembly and test facilities and is our 5% joint venture partner in our other Chengdu assembly and test facility; however, we have no material transactions with Ya Guang. We also purchase materials from Jiyuan Crystal Photoelectric Frequency Technology Ltd (“JCP”), a frequency control product manufacturing company in which we have made an equity investment and account for that investment using the equity method of accounting.      

-18-


 

The Audit Committee of the Board reviews all related party transactions for potential conflict of interest situations on an ongoing basis, all in accordance with such procedures as the Audit Committee may adopt from time to time.

The table below sets forth net sales to and purchases from related parties:

 

 

Three Months Ended

 

 

March 31,

 

 

2020

 

 

2019

 

LSC

 

 

 

 

 

 

 

Net sales

$

128

 

 

$

188

 

Purchases

$

2,748

 

 

$

4,412

 

Nuvoton

 

 

 

 

 

 

 

Purchases

$

1,644

 

 

$

1,267

 

Keylink

 

 

 

 

 

 

 

Net sales

$

3,985

 

 

$

2,815

 

Purchases

$

405

 

 

$

605

 

JCP

 

 

 

 

 

 

 

Purchases

$

156

 

 

$

160

 

 

 

 

 

 

 

 

 

The table below sets forth accounts receivable from, and accounts payable to, related parties:

 

 

March 31,

 

 

December 31,

 

 

2020

 

 

2019

 

LSC

 

 

 

 

 

 

 

Accounts receivable

$

128

 

 

$

184

 

Accounts payable

$

2,055

 

 

$

2,154

 

Nuvoton

 

 

 

 

 

 

 

Accounts payable

$

875

 

 

$

1,055

 

Keylink

 

 

 

 

 

 

 

Accounts receivable

$

25,536

 

 

$

31,598

 

Accounts payable

$

22,100

 

 

$

28,244

 

JCP

 

 

 

 

 

 

 

Accounts payable

$

181

 

 

$

173

 

 

Note 13 –Acquisitions

Savitech Acquisition

 

On February 5, 2020, the Company entered into an agreement to invest up to approximately $14.2 million to acquire at least 51% of Savitech Corporation (“Savitech”), a fabless semiconductor design company located in Zhubei City, Taiwan.  The Company will make the investment in two tranches.  The first tranche of $5.6 million, which provided the Company with a 33.6% ownership of Savitech, was made on March 4, 2020.  The initial tranche was funded with cash on hand. The second tranche, currently recorded in other long-term liabilities, as shown in the table below, and currently valued at $7.3 million  will increase the Company’s ownership to at least 51% of Savitech. The second tranche will be paid on June 30, 2021, provided Savitech achieves previously agreed-to revenue levels.  If revenue levels are not achieved the Company will pay less than the maximum $8.6 million, but regardless of the amount paid, will still acquire at least 51% of Savitech.

 

-19-


 

The Company recorded the purchase of Savitech as a business acquisition and will consolidate Savitech into their operations, based on the voting model, with a non-controlling interest related to the interest Diodes does not own in Savitech. The Company purchased Savitech in order to increase the Company’s integrated circuit business.   Total purchase consideration recorded was $12.9 million. The goodwill will not be tax deductible. The Company also incurred acquisition costs of approximately $0.1 million that were recognized in selling, general and administrative expense. The table below sets forth the preliminary fair value of the assets and liabilities recorded in the acquisition and the corresponding line item in which the item is recorded in our condensed consolidated balance sheet at the date of acquisition. The acquisition accounting is not final as deferred taxes, the contingent consideration payment and goodwill are being finalized.  We expect the acquisition accounting to be finalized in the second or third quarter of 2020.

 

 

Cash and cash equivalents

 

$

6.2

 

Prepaid expenses and other

 

 

0.7

 

Goodwill

 

 

10.8

 

Intangible assets, net

 

 

6.1

 

Other long-term assets

 

 

0.3

 

Accrued liabilities and other

 

 

0.4

 

Other long-term liabilities

 

 

7.3

 

Noncontrolling interest

 

 

10.8

 

 

Wafer Fabrication Facility Acquisition

On April 1, 2019, the Company completed the previously announced acquisition of a wafer fabrication facility located in Greenock, Scotland (“GFAB”). The Company recorded the purchase of GFAB as a business acquisition. The Company purchased GFAB in order to increase the Company’s wafer production capacity.  Total consideration paid by the Company was $33.2 million and was funded by advances under the revolving portion of our long-term credit facility.  The facility and assets were wholly acquired, and there is no remaining minority interest.    The goodwill will not be tax deductible.  The Company also incurred acquisition costs of approximately $0.6 million that were recognized in selling, general and administrative expense.  Due to a lack of available data we are unable to provide historical financial pro forma data.  The table below sets forth the fair value of the assets and liabilities recorded in the GFAB acquisition and the corresponding line item in which the item is recorded in our condensed consolidated balance sheet.

 

 

Property, plant and equipment, net

$

24.4

 

Inventories

 

3.6

 

Prepaid expenses and other

 

5.2

 

Goodwill

 

0.9

 

Deferred tax liabilities

 

 

1.0

 

 

 

 

 

-20-


 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Except for the historical information contained herein, the matters addressed in this Item 2 constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as identified under the heading “Cautionary Statement for Purposes of the “Safe Harbor” Provision of the Private Securities Litigation Reform Act of 1995” herein. Such forward-looking statements are subject to a variety of risks and uncertainties, including those discussed below under the heading “Risk Factors” and elsewhere in this Quarterly Report on Form 10-Q, that could cause actual results to differ materially from those anticipated by our management. The Private Securities Litigation Reform Act of 1995 (the “PSLRA”) provides certain “safe harbor” provisions for forward-looking statements. All forward-looking statements made in this Quarterly Report on Form 10-Q are made pursuant to the PSLRA. We undertake no obligation to publicly release the results of any revisions to our forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unexpected events. Unless the context otherwise requires, the words “Diodes,” the “Company,” “we,” “us” and “our” refer to Diodes Incorporated and its subsidiaries. Dollar amounts and share amounts are presented in thousands, except per share amounts, unless otherwise noted.

 

This management’s discussion should be read in conjunction with the management’s discussion included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019 (“Form 10-K”), previously filed with Securities and Exchange Commission (“SEC”) on February 12, 2020.

Overview

We are a leading global manufacturer and supplier of high-quality, application-specific standard products within the broad discrete, logic, analog and mixed-signal semiconductor markets. For detailed information, see Note 1 – Summary of Operations and Significant Accounting Policies, included in the condensed consolidated financial statements in Item 1 above.  Our products are sold primarily throughout Asia, North America and Europe. We believe that our focus on application-specific standard products utilizing innovative, highly efficient packaging and cost-effective process technologies, coupled with our collaborative, customer-focused product development, provides us with a meaningful competitive advantage relative to other semiconductor companies.

Factors Relevant to Our Results of Operations for the Three Months Ended March 31, 2020

 

During the first quarter of 2020, net sales were $280.7 million, a decrease of 7.1% from the $302.3 million in the first  quarter of 2019, and a decrease of 6.8% from the $301.2 million in the fourth quarter of 2019;

 

Gross profit was $95.8 million, compared to $112.4 million of gross profit in the first quarter of 2019, and $109.4 million in the fourth quarter of 2019;

 

Gross profit margin was 34.1%, compared to gross profit margin of 37.2% in the first quarter of 2019, and 36.3% in the fourth quarter of 2019;

 

Net income was $20.2 million, or $0.38 per diluted share, compared to net income of $31.7 million, or $0.62 per diluted share, in the first quarter of 2019, and net income of $47.2 million, or $0.90 per diluted share in the fourth quarter or 2019; and

 

Cash flow from operations was $53.7 million.  Net cash flow was a positive $11.4 million, which includes a paydown of $16.6 million of long-term debt and $14.2 million of capital expenditures.

Recent Developments

LSC Acquisition

In the third quarter of 2019 we entered into a Share Swap Agreement that provides for the acquisition of Lite-On Semiconductor Corporation (“LSC”) and its subsidiaries by the Company. At the effective date of the transaction, each share of LSC will be converted into the right to receive TWD $42.50 per share in cash, or approximately US $1.39 per share based on March 31, 2020 exchange rates.  The aggregate consideration payable by the Company, based on the March 31, 2020 exchange rate, is approximately $426 million. This amount is subject to change, based on the Taiwan dollar to United States dollar exchange rate at closing. The acquisition received LSC shareholder approval in October 2019, and Taiwan regulatory approval in March 2020.  We anticipate completing the acquisition in the second half of 2020, subject to customary closing conditions and remaining regulatory approvals.  We expect to fund the purchase price of the transaction primarily with proceeds from an anticipated new bank financing arrangement.

-21-


 

COVID-19

In March 2020, the World Health Organization categorized COVID-19 as a pandemic, and the President of the United States declared the COVID-19 outbreak a national emergency. COVID-19 continues to spread throughout the United States and other countries across the world, including the countries in which we operate.  The duration and severity of the effects of COVID-19 are currently unknown. 

Developments have been occurring rapidly with respect to the spread of COVID-19 and its impact on human health and businesses.  New and changing government actions to address the COVID-19 pandemic have been occurring on a daily basis. We have been closely monitoring the COVID-19 pandemic and its impacts and potential impacts on our business.  However, because developments with respect to the spread of COVID-19 and its impacts have been occurring so rapidly and because of the unprecedented nature of the pandemic, we are unable to predict the extent and duration of any possible adverse financial impact of COVID-19 on our business, financial condition and results of operations.  

We remain focused on the safety and well-being of our stakeholders and on the service of our customers.  We will continuously review and assess the rapidly-changing COVID-19 pandemic and its impacts on our customers, our suppliers and our business so that we can seek to address those impacts.  In the first quarter of 2020, following the extended Chinese New Year, we delayed the start of our manufacturing production in China and at the end of the first quarter of 2020 we temporarily closed our wafer fabrication facilities located in the United Kingdom.  Our operations in China and the United Kingdom have both resumed full production.  

As of March 31, 2020, our cash, cash equivalents, and short-term investments were $272.4 million, and we had access to additional borrowing capacity of $250 million under the revolving portion our U.S. Credit Facility, which we believe assures us adequate liquidity to manage the impacts of the COVID-19 pandemic on our business to cover cash needs for working capital and capital expenditures for at least the next 12 months. 

 

Please see “Risk Factors - The ultimate impact of the COVID-19 pandemic outbreak cannot be estimated at this time, but it may have a material adverse effect on our business, financial condition and results of operations.” in Item 1A of this Quarterly Report on Form 10-Q for an additional discussion of risks and potential risks of the COVID-19 pandemic on our business, financial condition and results of operations.

Results of Operations for the Three Months Ended March 31, 2020 and 2019

The table below sets forth the condensed consolidated statement of operations line items as a percentage of net sales.

 

 

Percent of  Net Sales

 

 

Three Months Ended March 31,

 

 

2020

 

 

2019

 

Net sales

 

100

%

 

 

100

%

Cost of goods sold

 

(66

)

 

 

(63

)

Gross profit

 

34

 

 

 

37

 

Total operating expense

 

25

 

 

 

23

 

Income from operations

 

9

 

 

 

14

 

Total other expense

 

-

 

 

 

-

 

Income before income taxes and noncontrolling interest

 

9

 

 

 

14

 

Income tax provision

 

(2

)

 

 

(3

)

Net income

 

7

 

 

 

11

 

Net income attributable to common stockholders

 

7

 

 

 

11

 

 

-22-


 

The following table and discussion explains in greater detail our consolidated operating results and financial condition for the three months ended March 31, 2020, compared to the three months ended March 31, 2019. This discussion should be read in conjunction with the condensed consolidated financial statements and notes thereto appearing elsewhere in this Quarterly Report on Form 10-Q.

 

 

Three Months Ended

 

 

March 31,

 

 

 

 

 

 

 

 

 

 

2020

 

 

2019

 

 

Increase/(Decrease)

 

 

% Change

 

Net sales

$

280,717

 

 

$

302,293

 

 

$

(21,576

)

 

 

(7.1

%)

Cost of goods sold

 

184,875

 

 

 

189,882

 

 

 

(5,007

)

 

 

(2.6

%)

Gross profit

 

95,842

 

 

 

112,411

 

 

 

(16,569

)

 

 

(14.7

%)

Total operating expense

 

69,990

 

 

 

70,288

 

 

 

(298

)

 

 

(0.4

%)

Interest income

 

273

 

 

 

875

 

 

 

(602

)

 

 

(68.8

%)

Interest expense

 

(1,245

)

 

 

(2,145

)

 

 

(900

)

 

 

(42.0

%)

Foreign currency gain (loss), net

 

75

 

 

 

(64

)

 

 

(139

)

 

 

(217.2

%)

Other income

 

1

 

 

 

1,245

 

 

 

(1,244

)

 

 

(99.9

%)

Income tax provision

 

4,556

 

 

 

10,298

 

 

 

(5,742

)

 

 

(55.8

%)

 

Net sales decreased approximately $21.6 million for the three months ended March 31, 2020, compared to the same period last year.  This decrease in net sales reflects the global economic slowdown caused by the COVID-19 pandemic.  During the three months ended March 31, 2020, the Company delayed reopening its manufacturing facilities in China after the Chinese New Year period that was extended due to the COVID-19 pandemic.  Our revenues are also negatively impacted during the first quarter of each year due to seasonality.  Also as a result of the COVID-19 pandemic, late in March 2020, the Company temporarily shut down its manufacturing facilities in the United Kingdom.  Despite the overall decrease in net sales, the Company experienced continued growth in the automotive and computing end markets during the three months ended March 31, 2020. For the three months ended March 31, 2020, the automotive market represented 11% of total sales.  

The table below sets forth our revenue as a percentage of total revenue by end-user market for the three months ended March 31, 2020 and 2019:

 

 

Three Months Ended

 

 

March 31,

 

 

2020

 

 

2019

 

Industrial

26%

 

 

29%

 

Communications

23%

 

 

23%

 

Consumer

23%

 

 

23%

 

Computing

17%

 

 

15%

 

Automotive

11%

 

 

10%

 

 

Cost of goods sold decreased approximately $5.0 million for the three months ended March 31, 2020, compared to the same period last year, due, in part, to the decreased net sales during the first quarter of 2020.  As a percent of sales, cost of goods sold was 65.9% for the three months ended March 31, 2020, compared to 62.8% for the same period last year. Average unit cost increased approximately 13.0% for the three months ended March 31, 2020, compared to the same period last year, in part due to the shutdown of our manufacturing facilities due to the extended Chinese New Year period. For the three months ended March 31, 2020, gross profit decreased approximately 14.7% when compared to the same period last year. Gross profit margin for the three month periods ended March 31, 2020 and 2019 was 34.1% and 37.2%, respectively. The decrease in gross profit margin reflects the 7.1% decrease in revenue.

Operating expenses for the three months ended March 31, 2020, decreased approximately $0.3 million, or 0.4%, compared to the three months ended March 31, 2019. Selling, general and administrative expenses (“SG&A”) decreased approximately $1.5 million and research and development expenses (“R&D”) increased approximately $1.5 million, each as compared to the same period last year. Amortization of acquisition related intangibles decreased $0.3 million, compared to the same period last year. SG&A, as a percentage of sales, was 15.0% and 14.5% for the three months ended March 31, 2020 and 2019, respectively. R&D, as a percentage of sales, was 8.4% and 7.3% for the three months ended March 31, 2020 and 2019, respectively.  

-23-


 

Interest income decreased 68.8% for the three months ended March 31, 2020, compared to the same period last year, due to a reduction in short-term investments.  Interest expense decreased 42.0% for the three months ended March 31, 2020, compared to the same period last year. The decrease in interest expense for the three months ended March 31, 2020 was due to lower levels of debt partially along with lower interest rates on the floating rate portion of our debt.

We recognized an income tax expense of approximately $4.6 million and $10.3 million for the three months ended March 31, 2020 and 2019, respectively. The decrease in income taxes for 2020 compared to 2019 was primarily attributable to a decrease in pretax book income, a decrease in non-U.S. withholding taxes and a net increase in favorable U.S. permanent differences.

Financial Condition

 

Liquidity and Capital Resources

Our primary sources of liquidity are cash and cash equivalents, funds from operations and, if necessary, borrowings under our credit facilities.

Short-term debt

Our Asia subsidiaries maintain credit facilities with several financial institutions through our foreign entities worldwide totaling $162.8 million. At March 31, 2020, outstanding borrowings were $13.4 million and outstanding letters of credit were $0.4 million under the Asia credit facilities. Other than two Taiwanese credit facilities that are collateralized by assets, our foreign credit lines are unsecured, uncommitted, repayable on demand, terminable by the lender at any time and contain no restrictive covenants.  These credit facilities bear interest at LIBOR or similar indices plus a specified margin.  Interest payments are due monthly on outstanding amounts under the credit lines.

 

Long-term debt

We currently have a U.S. banking credit facility (the “U.S. Credit Facility”) under which we may draw up to $250 million on a revolving basis, in addition to a $250 million term loan.  The U.S. Credit Facility matures October 26, 2021.  The remaining portion of the term loan of the U.S. Credit Facility is repayable in part through quarterly installments that increase over time from $7.8 million in the first three quarters of 2020 to $9.4 million per quarter in the final year of the U.S. Credit Facility. We may, from time to time, request increases in the aggregate commitments under the U.S. Credit Facility of up to $200 million, subject to the lenders electing to increase their commitments or by means of the addition of new lenders, and subject to at least half of each increase in aggregate commitments being in the form of term loans, with the remaining amount of each increase being an increase in the amount of the revolving portion of the U.S. Credit Facility.  The U.S. Credit Facility contains certain financial and non-financial covenants, including, but not limited to, a maximum consolidated leverage ratio, a minimum consolidated fixed charge coverage ratio, and restrictions on liens, indebtedness, investments, fundamental changes, dispositions, and restricted payments (including dividends and share repurchases).  The obligations of the Company and the other borrowers under the U.S. Credit Facility are secured by substantially all of the assets of the Company, including controlling interests in its first-tier subsidiaries, and by specified assets of certain of its subsidiaries.  In addition to our U.S. credit facilities, our 51% owned subsidiary, ERIS Technology Corporation (“ERIS”), borrowed $13.4 million through a short term loan and $26.5 million on a long-term basis from local Taiwan banks in order to make an investment.  The ERIS debt has the following maturities: $0.2 million in 2020, $4.5 million in 2021, $4.9 million in 2022, $1.6 million in 2023, $12.6 million in 2024 and $2.7 million thereafter.

-24-


 

The details of our borrowings outstanding as of March 31, 2020 are set forth in the table below:

 

Description

 

Amount outstanding

 

Interest Rate

 

Maturity Date

Short-term debt:

 

 

 

 

 

 

Foreign credit lines

 

$13,397

 

Libor or other similar indices plus a specified margin

 

Various during

2020 - 2021

 

 

 

 

 

 

 

Long-term debt

 

 

 

 

 

 

Notes payable to Bank of Taiwan

 

4,135

 

Two-year savings rate +1..3%

 

June 2033

Notes payable to CTBC Bank

 

19,054

 

TAIBOR 3 month rate +.05%

 

May 2024

Notes payable to East Sun Bank

 

3,308

 

1-M deposit rate + 0.08%

 

December 2022

U.S. Credit facility:

 

 

 

 

 

 

Revolving portion

 

-

 

Libor + a specified margin

 

October 2021

Term portion

 

55,375

 

Libor + a specified margin

 

October 2021

Total long-term debt

 

81,872

 

 

 

 

Less: Current portion of long-term debt

 

(34,676)

 

 

 

 

Less: Unamortized debt issuance costs

 

(1,185)

 

 

 

 

Total long-term debt, net of current portion

 

$46,011

 

 

 

 

 

Our primary liquidity requirements have been to meet our inventory and capital expenditure needs and to fund on-going operations. At March 31, 2020 and December 31, 2019, our working capital was $532.3 million and $524.6 million, respectively. We expect cash generated by our operations together with existing cash, cash equivalents, short-term investments and available credit facilities to be sufficient to cover cash needs for working capital and capital expenditures for at least the next 12 months.  

Capital expenditures (including accrued capital expenditures) for the three months ended March 31, 2020 and 2019 were $12.6 million and $16.3 million, respectively.  For the first three months of 2020 capital expenditures were approximately 4.5% of our net sales, which is in slightly below our capital spending target range of 5% to 9% of net sales.  

Our undistributed foreign earnings continue to be indefinitely reinvested in foreign operations, with limited exceptions related to earnings of certain European and Asian subsidiaries.  As of March 31, 2020, our foreign subsidiaries held approximately $143.6 million of cash, cash equivalents and investments of which approximately $21.4 million would be subject to a potential non-U.S. withholding tax if distributed outside the country in which the cash is currently held.  Of this total, $9.2 million is held in China.

As of March 31, 2020, we had short-term investments totaling $2.9 million. These investments are highly liquid with maturity dates greater than three months at the date of purchase. We generally can access these investments in a relatively short time frame but in doing so we generally forfeit all earned and future interest income.

Discussion of Cash Flow

Our primary source of liquidity is cash flow from operations. Additional sources of liquidity are cash and cash equivalents, short-term investments and our credit facilities. Our cash and cash equivalents increased from $258.4 million at December 31, 2019 to $269.5 million at March 31, 2020.  

The table below sets forth a summary of the condensed consolidated statements of cash flows:

 

 

Three Months Ended March 31,

 

 

2020

 

 

2019

 

 

Change

 

Net cash flows provided by operating activities

$

53,675

 

 

$

69,889

 

 

$

(16,214

)

Net cash and cash equivalents used in investing activities

 

(17,558

)

 

 

(17,152

)

 

 

(406

)

Net cash and cash equivalents (used in) provided by financing activities

 

(21,397

)

 

 

9,627

 

 

 

(31,024

)

Effect of exchange rate changes on cash and cash equivalents

 

(3,315

)

 

 

(1,890

)

 

 

(1,425

)

Net increase in cash and cash equivalents, including restricted cash

$

11,405

 

 

$

60,474

 

 

$

(49,069

)

 

-25-


 

Operating Activities

Net cash flows provided by operating activities for the three months ended March 31, 2020 was $53.7 million.  Net cash flows provided by operating activities for the three months ended March 31, 2020 resulted from net income of $20.4 million, depreciation and amortization of intangible assets of $27.0 million, share-based compensation of $4.7 million and an increase in noncash working capital accounts of $0.8 million. Net cash flows provided by operating activities for the three months ended March 31, 2019 was $69.9 million.  Net cash flows provided by operating activities resulted from net income of $31.7 million, depreciation and amortization of intangible assets of $26.6 million, share-based compensation of $4.5 million and an increase in noncash working capital accounts of $7.3 million. 

Investing Activities

Net cash and cash equivalents used in investing activities was $17.6 million for the three months ended March 31, 2020. Net cash and cash equivalents used in investing activities was primarily due to the purchase of property, plant and equipment of $14.2 million and the additional investment by the Company’s subsidiary ERIS in Yea-Shin of $6.1 million, bring ERIS’ ownership of Yea-Shin to approximately 97%. These outflows of cash were partially offset by net proceeds from the maturity of short-term investments of $1.9 million for the three months ended March 31, 2020. Net cash and cash equivalents used in investing activities for the three months ended March 31, 2019 was primarily due to the purchase of property, plant and equipment of $18.6 million, partially offset by net proceeds received by the sale of short-term investments of $0.8 million.

Financing Activities

Net cash and cash equivalents used in financing activities was $21.4 million for the three months ended March 31, 2020. Net cash used in financing activities in the three months ended March 31, 2020 consisted primarily of $16.6 million net repayments of long-term debt and taxes paid on net share settlement of $4.5 million.  Net cash and cash equivalents provided by financing activities was $9.6 million for the three months ended March 31, 2019. Net cash and cash equivalents provided in the three months ended March 31, 2019 consisted primarily of proceeds from the issuance of Common Stock related to stock option exercises of $6.7 million and increases under our line of credit and short-term debt of $3.6 million.  

Use of Derivative Instruments and Hedging

We use interest rate swaps, foreign exchange forward contracts and cross currency swaps to provide a level of protection against interest rate risks and foreign exchange exposure.

Hedges of Interest Rate Risk

The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps, including interest rate collars, as part of its interest rate risk management strategy.  Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount.

Hedges of Foreign Currency Risk

We are exposed to fluctuations in various foreign currencies against our different functional currencies. We use foreign currency forward agreements to manage this exposure and to preserve the economic value of foreign currency denominated monetary assets and liabilities; these instruments are not designated for hedge accounting treatment in accordance with ASC 815.  The fair value of our foreign exchange hedges approximates zero.

Off-Balance Sheet Arrangements

We do not have any transactions, arrangements or other relationships with unconsolidated entities that will affect our liquidity or capital resources. We have no special purpose entities that provide off-balance sheet financing, liquidity or market or credit risk support, nor do we engage in leasing, swap agreements, or outsourcing of research and development services that could expose us to liability that is not reflected on the face of our financial statements.

-26-


 

Contractual Obligations

There have been no material changes in our Contractual Obligations as disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019, filed with the SEC on February 12, 2020.  

Critical Accounting Policies

Our critical accounting policies are described in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, and in the notes to our consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December 31, 2019 filed with the SEC on February 12, 2020. Any new accounting policies or updates to existing accounting policies as a result of new accounting pronouncements have been discussed in the notes to our condensed consolidated financial statements in this Quarterly Report on Form 10-Q in Note 1 – Summary of Operations and Significant Accounting Policies. The application of our critical accounting policies may require management to make judgments and estimates about the amounts reflected in the condensed consolidated financial statements. Management uses historical experience and all available information to make these estimates and judgments, and different amounts could be reported using different assumptions and estimates.

Recently Issued Accounting Pronouncements

See Note 1 - Summary of Operations and Significant Accounting Policies, of the Notes to Condensed Consolidated Financial Statements, for detailed information regarding the status of recently issued accounting pronouncements.

Available Information

Our Internet address is http://www.diodes.com.  Information included on, or accessible through, our website shall not be deemed to form a part of the Quarterly Report on Form 10-Q. We make available, free of charge through our Internet website, our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, proxy statements, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (“Exchange Act”) as soon as reasonably practicable after such material is electronically filed with or furnished to the SEC. Our website also provides access to investor financial information, including SEC filings and press releases, as well as stock quotes and information on corporate governance compliance.

Cautionary Statement for Purposes of the “Safe Harbor” Provision of the Private Securities Litigation Reform Act of 1995

Except for the historical information contained herein, the matters addressed in this Quarterly Report on Form 10-Q constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act of 1934. We generally identify forward-looking statements by the use of terminology such as “may,” “will,” “could,” “should,” “potential,” “continue,” “expect,” “intend,” “plan,” “estimate,” “anticipate,” “believe,” or similar phrases or the negatives of such terms. Such forward-looking statements are subject to a variety of risks and uncertainties, including those discussed under “Risk Factors” and elsewhere in this Quarterly Report on Form 10-Q, and in other reports we file with the SEC from time to time, that could cause actual results to differ materially from those anticipated by our management. The PSLRA provides certain “safe harbor” provisions for forward-looking statements. All forward-looking statements made in this Quarterly Report on Form 10-Q are made pursuant to the PSLRA.

All forward-looking statements contained in this Quarterly Report on Form 10-Q are subject to, in addition to the other matters described in this Quarterly Report on Form 10-Q, a variety of significant risks and uncertainties. The following discussion highlights some of these risks and uncertainties. Further, from time to time, information provided by us or statements made by our employees may contain forward-looking information. There can be no assurance that actual results or business conditions will not differ materially from those set forth or suggested in such forward-looking statements as a result of various factors, including those discussed below.

For more detailed discussion of these factors, see the “Risk Factors” discussion in Item 1A of our most recent Annual Report on Form 10-K as filed with the SEC and in Part II, Item 1A of this report The forward-looking statements included in this Quarterly Report on Form 10-Q are made only as of the date of this report, and we undertake no obligation to update the forward-looking statements to reflect subsequent events or circumstances.

-27-


 

Risk Factors

RISKS RELATED TO OUR BUSINESS

 

The success of our business depends on the strength of the global economy and the stability of the financial markets, and any weaknesses in these areas may have a material adverse effect on our net sales, operating results and financial condition.

During times of difficult market conditions, our fixed costs combined with lower net sales and lower profit margins may have a negative impact on our business, operating results and financial condition.

Downturns in the highly cyclical semiconductor industry or changes in end-market demand could adversely affect our operating results and financial condition.

The semiconductor business is highly competitive, and increased competition may harm our business, operating results and financial condition.

One of our external suppliers is also a related party. The loss of this supplier could harm our business, operating results and financial condition.

Delays in initiation of production at facilities due to implementing new production techniques or resolving problems associated with technical equipment malfunctions could adversely affect our manufacturing efficiencies, operating results and financial condition.

We are and will continue to be under continuous pressure from our customers and competitors to reduce the price of our products, which could adversely affect our growth and profit margins.

Our customers require our products to undergo a lengthy and expensive qualification process without any assurance of product sales and may demand to audit our operations from time to time.  A failure to qualify a product or a negative audit finding could adversely affect our net sales, operating results and financial condition.

Our customer orders are subject to cancellation or modification usually with no penalty. High volumes of order cancellation or reduction in quantities ordered could adversely affect our net sales, operating results and financial condition.

Production at our manufacturing facilities could be disrupted for a variety of reasons, including natural disasters and other extraordinary events, which could prevent us from producing enough of our products to maintain our sales and satisfy our customers’ demands and could adversely affect our operating results and financial condition.

New technologies could result in the development of new products by our competitors and a decrease in demand for our products, and we may not be able to develop new products to satisfy changes in demand, which would adversely affect our net sales, market share, operating results and financial condition.

We may be adversely affected by any disruption in our information technology systems, which could adversely affect our cash flows, operating results and financial condition.

We may be subject to claims of infringement of third-party intellectual property rights or demands that we license third-party technology, which could result in significant expense, reduction in our intellectual property rights and a negative impact on our business, operating results and financial condition.

We depend on third-party suppliers for timely deliveries of raw materials, manufacturing services, product and process development, parts and equipment, as well as finished products from other manufacturers, and our reputation with customers, operating results and financial condition could be adversely affected if we are unable to obtain adequate supplies in a timely manner.

If we do not succeed in continuing to vertically integrate our business, we will not realize the cost and other efficiencies we anticipate, which could adversely affect our ability to compete, our operating results and financial condition.

Part of our growth strategy involves identifying and acquiring companies. We may be unable to identify suitable acquisition candidates or consummate desired acquisitions and, if we do make any acquisitions, we may be unable to successfully integrate any acquired companies with our operations, which could adversely affect our business, operating results and financial condition.

-28-


 

We are subject to litigation risks, including securities class action litigation and intellectual property litigation, which may be costly to defend and the outcome of which is uncertain and could adversely affect our business and financial condition.

We are subject to many environmental laws and regulations that could result in significant expenses and could adversely affect our business, operating results and financial condition.

Our products, or products we purchase from third parties for resale, may be found to be defective and, as a result, warranty claims and product liability claims may be asserted against us and we may not have recourse against our suppliers, which may harm our business, reputation with our customers, operating results and financial condition.

We may fail to attract or retain the qualified technical, sales, marketing, finance and management/executive personnel required to operate our business successfully, which could adversely affect our business, operating results and financial condition.

We may not be able to achieve future growth, and any such growth may place a strain on our management and on our systems and resources, which could adversely affect our business, operating results and financial condition.

Obsolete inventories as a result of changes in demand for our products and change in life cycles of our products could adversely affect our business, operating results and financial condition.

If our direct sales customers do not design our products into their applications, our net sales may be adversely affected.

We are subject to interest rate risk that could have an adverse effect on our cost of working capital and interest expenses, which could adversely affect our business, operating results and financial condition.

Our hedging strategies may not be successful in mitigating our risks associated with interest rates or foreign exchange exposure or our counterparties might not perform as agreed.

We may have a significant amount of debt with various financial institutions worldwide. Any indebtedness could adversely affect our business, operating results, financial condition and our ability to meet payment obligations under such debt.

Restrictions in our credit facilities may limit our business and financial activities, including our ability to obtain additional capital in the future.

Our business benefits from certain Chinese government incentives. Expiration of, or changes to, these incentives could adversely affect our operating results and financial condition.

We operate a global business through numerous foreign subsidiaries, and there is a risk that tax authorities will challenge our transfer pricing methodologies or legal entity structures, which could adversely affect our operating results and financial condition.

The value of our benefit plan assets and liabilities is based on estimates and assumptions, which may prove inaccurate and the actual amount of expenses recorded in the consolidated financial statements could differ materially from the assumptions used.

Changes in actuarial assumptions for our defined benefit plan could increase the volatility of the plan’s asset value, require us to increase cash contributions to the plan and have a negative impact on our cash flows, operating results and financial condition.

Certain of our customers and suppliers require us to comply with their codes of conduct, which may include certain restrictions that may substantially increase our cost of doing business as well as have an adverse effect on our operating efficiencies, operating results and financial condition.

Compliance with government regulations and customer demands regarding the use of “conflict minerals” may result in increased costs and may have a negative impact on our business, operating results and financial condition.

There are risks associated with previous and future acquisitions. We may ultimately not be successful in overcoming these risks or any other problems encountered in connection with acquisitions.

-29-


 

If we fail to maintain an effective system of internal controls or discover material weaknesses in our internal control over financial reporting, we may not be able to report our financial results accurately or detect fraud, which could harm our business and the trading price of our Common Stock.

Terrorist attacks, or threats or occurrences of other terrorist activities, whether in the U.S. or internationally, may affect the markets in which our Common Stock trades, the markets in which we operate and our operating results and financial condition.

System security risks, data protection breaches, cyber-attacks and other related cybersecurity issues could disrupt our internal operations, and any such disruption could reduce our expected net sales, increase our expenses, damage our reputation and adversely affect our stock price.

RISKS RELATED TO OUR INTERNATIONAL OPERATIONS

Our international operations subject us to risks that could adversely affect our operations.

We have significant operations and assets in China, the U.K., Germany, Hong Kong and Taiwan and, as a result, will be subject to risks inherent in doing business in those jurisdictions, which may adversely affect our financial performance and operating results.

Significant uncertainties related to changes in governmental policies and participation in international trading partnerships or economic unions currently exist, and, depending upon how such uncertainties are resolved, the changes could have a material adverse effect on us.

Tariffs or other restrictions imposed by the United States Trade Representative may affect our operations in the U.S., may disrupt our activities in the U.S., may have an adverse impact on our profitability and results of operations and may encourage the independent development in China of products and electronic components that will compete with or displace our products and components, resulting in an adverse impact on our Chinese business.

The U.K.’s exit from the European Union (“E.U.”) will continue to have uncertain effects and could adversely impact our business, results of operations and financial condition.

A slowdown in the Chinese economy could limit the growth in demand for electronic devices containing our products, which would have a material adverse effect on our business, operating results and prospects.

Economic regulation in China could materially and adversely affect our business, operating results and prospects.

We could be adversely affected by violations of the United States’ Foreign Corrupt Practices Act, the U.K.’s Bribery Act 2010, China’s anti-corruption campaign and similar worldwide anti-bribery laws.

We are subject to foreign currency risk as a result of our international operations.

China is experiencing rapid social, political and economic change, which has increased labor costs and other related costs that could make doing business in China less advantageous than in prior years. Increased labor costs in China could adversely affect our business, operating results and financial condition.

We may not continue to receive preferential tax treatment in Asia, thereby increasing our income tax expense and reducing our net income.

The distribution of any earnings of certain foreign subsidiaries may be subject to foreign income taxes, thus reducing our net income.

We could be adversely affected by the compromise or theft of our technology, know-how, data or intellectual property or a requirement that we yield rights in technology, know-how, data stored in foreign jurisdictions or intellectual property that we use in such foreign jurisdictions.

-30-


 

RISKS RELATED TO OUR COMMON STOCK

Variations in our quarterly operating results may cause our stock price to be volatile.

We may enter into future acquisitions and take certain actions in connection with such acquisitions that could adversely affect the price of our Common Stock.

Our directors, executive officers and significant stockholders hold a substantial portion of our Common Stock, which may lead to conflicts with other stockholders over corporate transactions and other corporate matters.

We were formed in 1959, and our early corporate records are incomplete. As a result, we may have difficulty in assessing and defending against claims relating to rights to our Common Stock purporting to arise during periods for which our records are incomplete.

Non-cash tender offers, debt equity swaps or equity exchanges to consummate our business activities are likely to have the effect of diluting the ownership interest of existing stockholders, including qualified stockholders who receive shares of our Common Stock in such business activities.

Anti-takeover effects of certain provisions of Delaware law and our Certificate of Incorporation and Bylaws, may hinder a take-over attempt.

Section 203 of Delaware General Corporation Law may deter a take-over attempt.

Certificate of Incorporation and Bylaw Provisions may deter a take-over attempt.


-31-


 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

There have been no material changes to our market risks as disclosed in our Annual Report on Form 10-K for the year ended December 31, 2019, filed with the SEC on February 12, 2020.

Item 4. Controls and Procedures.

Our Chief Executive Officer, Keh-Shew Lu, and Chief Financial Officer, Brett R. Whitmire, with the participation of our management, carried out an evaluation, as of March 31, 2020, of the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)). Based upon that evaluation, the Chief Executive Officer and the Chief Financial Officer believe that, as of the end of the period covered by this Quarterly Report on Form 10-Q, our disclosure controls and procedures are effective at the reasonable assurance level to ensure that information required to be included in this report is:

 

recorded, processed, summarized and reported within the time period specified in the Commission’s rules and forms; and

 

accumulated and communicated to our management, including the Chief Executive Officer and the Chief Financial Officer, to allow timely decisions on required disclosure.

Disclosure controls and procedures, no matter how well designed and implemented, can provide only reasonable assurance of achieving an entity’s disclosure objectives. The likelihood of achieving such objectives is affected by limitations inherent in disclosure controls and procedures. These include the fact that human judgment in decision-making can be faulty and that breakdowns in internal control can occur because of human failures such as simple errors, mistakes or intentional circumvention of the established processes.

 

 

Changes in Controls over Financial Reporting

 

There was no change in our internal control over financial reporting, known to our Chief Executive Officer or Chief Financial Officer, that occurred in the three months ended March 31, 2020, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

 

-32-


 

PART II—OTHER INFORMATION

 

 

The Company is not a party to any pending litigation that we consider material.

From time to time, we are involved in various legal proceedings that arise in the normal course of business. While we intend to defend any lawsuit vigorously, we presently believe that the ultimate outcome of any pending legal proceeding will not have any material adverse effect on our financial position, cash flows or operating results. However, litigation is subject to inherent uncertainties, and unfavorable rulings could occur. An unfavorable ruling could include monetary damages, which could impact our business and operating results for the period in which the ruling occurs or future periods.

Item 1A. Risk Factors.

Except as identified in the additional Risk Factor set out below, there have been no material changes to our risk factors from those disclosed in the "Risk Factors" section of our Annual Report on Form 10-K for the year ended December 31, 2019, filed with the Securities and Exchange Commission on February 12, 2020.

The ultimate impact of the COVID-19 pandemic outbreak cannot be estimated at this time, but it may have a material adverse effect on our business, financial condition and results of operations.

In March 2020, the World Health Organization categorized COVID-19 as a pandemic, and the President of the United States declared the COVID-19 outbreak a national emergency. COVID-19 continues to spread throughout the United States and other countries across the world, and the duration, severity of its effects and ultimate impact to the world’s population and financial impact are currently unknown. National, state and local governments have responded to the COVID-19 pandemic in a variety of ways, including, without limitation, by declaring states of emergency, restricting people from gathering in groups or interacting within a certain physical distance (i.e., social distancing), and ordering businesses to close or limit operations and ordering people to stay at home (i.e., shelter in place).

Given these governmental actions, there is no assurance that we will be permitted to operate under every future government order or other restriction and in every location where we maintain operations and may be required to limit our operations at, or close, certain locations in the future. Any such long-term limitations or closures would have a material adverse impact on our ability to service our customers and on our business, financial condition and results of operations.  In particular, any long-term limitations on, or long-term closures of, our manufacturing facilities in Asia or Europe would have a negative adverse impact on our ability to manufacture, sell and ship products and service customers and would have a material adverse impact on our business, financial condition and results of operations. In the first quarter of 2020, following the extended Chinese New Year, we delayed the start of our manufacturing production in China and at the end of the first quarter of 2020 we temporarily closed our wafer fabrication facilities located in the United Kingdom. As of the date of this report, our operations in China and the United Kingdom have both resumed full production.  However, we can provide no assurances that those facilities or any of our other facilities may not suffer similar closures or disruptions in the future.

While the Company has already experienced negative impacts from the COVID-19 pandemic to its results of operations, cash flows and financial condition, in light of the current level of uncertainty over the economic and operational impacts of COVID-19 we cannot reasonably estimate the total impact that COVID-19 will have on our results of operations, cash flows or financial condition at this time. Risks and complications in the Company’s business from COVID-19 include, but are not limited to, changes in ordering patterns and demand for our products and losses in efficiency due to travel limitations and regulations compelling employees to work from home.  While the Company has not experienced a material increase in technology spending, if employees are forced to continue working remotely it could become necessary to increase information technology spending.  Although the Company has not experienced a significant business disruption due to teleworking arrangements, the imposition of increased self-isolation protocols could negatively impact the ability of employees to travel to the Company’s production facilities and possibly create ongoing business disruptions.  The limitations could negatively affect the Company’s ability to produce, sell and transport its products.  The Company’s consolidated financial statements presented herein reflect estimates and assumptions made by management that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenue and expenses during the reporting periods presented. Such estimates and assumptions affect, among other things, the Company’s goodwill, long-lived asset and indefinite-lived intangible asset valuation; inventory valuation; equity investment valuation; assessment of the annual effective tax rate; valuation of deferred income taxes and income tax contingencies; the allowance for doubtful accounts; measurement of compensation cost for certain share-based awards and cash bonus plans; and pension plan assumptions. In addition, depending on the extent and duration of the COVID-19 pandemic, healthcare insurance premiums could increase, increasing our healthcare costs.

-33-


 

In addition, the COVID-19 pandemic may cause disruptions, and in some cases severe disruptions, to the business and operations of our suppliers and customers as a result of quarantines, worker absenteeism as a result of illness or other factors, social distancing measures and other travel, health-related, business or other restrictions.  Certain of our customers and suppliers may in the future be required to close down or operate at a lower capacity, which would adversely impact our business, financial condition and results of operations. Because of the rapid onset of the COVID-19 pandemic, some of our customers could experience financial difficulties resulting in such customers being unable to pay for products they ordered from us before the COVID-19 pandemic emerged. There can be no assurance that any decrease in sales resulting from the COVID-19 pandemic will be offset by increased sales in the future.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

 

 

-34-


 

Item 6. Exhibits.  

 

Number

 

Description

  

Form

  

Date of First Filing

  

Exhibit
Number

  

Filed
Herewith

 

    3.1

 

 

Certificate of Incorporation, as amended

  

 

10-K

 

 

February 20, 2018

 

 

3.1

 

 

 

    3.2

 

 

Amended By-laws of the Company as of January 6, 2016

  

 

8-K

 

 

January 11, 2016

 

 

3.1

 

 

 

    4.1

 

 

Form of Certificate for Common Stock, par value $0.66 2/3 per share

  

 

S-3

 

 

August 25, 2005

 

 

4.1

 

 

 

  10.1

 

Consent and Amendment No. 4 to Amended and Restated Credit Agreement

 

 

 

 

 

 

 

 

X

 

  10.2

 

 

Consent and Amendment No. 5 to Amended and Restated Credit Agreement and Limited Waiver

 

 

 

 

 

 

 

 

X

  31.1

 

Certification Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

  

 

 

 

 

 

 

 

X

 

  31.2

 

 

Certification Pursuant to Rule 13a-14(a) /15d-14(a) of the Securities Exchange Act of 1934, adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

  

 

 

 

 

 

 

 

X

 

  32.1*

 

 

Certification Pursuant to 18 U.S.C. 1350 adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

  

 

 

 

 

 

 

 

X

 

  32.2*

 

 

Certification Pursuant to 18 U.S.C. 1350 adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

  

 

 

 

 

 

 

 

X

 

101.INS

 

 

Inline XBRL Instance Document- the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

 

 

 

 

 

 

 

 

X

 

101.SCH

 

 

Inline XBRL Taxonomy Extension Schema

  

 

 

 

 

 

 

 

X

 

101.CAL

 

 

Inline XBRL Taxonomy Extension Calculation Linkbase

  

 

 

 

 

 

 

 

X

 

101.DEF

 

 

Inline XBRL Taxonomy Extension Definition Linkbase

  

 

 

 

 

 

 

 

X

 

101.LAB

 

 

Inline XBRL Taxonomy Extension Labels Linkbase

  

 

 

 

 

 

 

 

X

 

101.PRE

 

 

Inline XBRL Taxonomy Extension Presentation Linkbase

  

 

 

 

 

 

 

 

X

 

104

 

Cover Page Interactive Data File, formatted in Inline XBRL

 

 

 

 

 

 

 

 

X

*

A certification furnished pursuant to Item 601(b)(32) of the Regulation S-K will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.

PLEASE NOTE: It is inappropriate for investors to assume the accuracy of any covenants, representations or warranties that may be contained in agreements or other documents filed as exhibits to this Quarterly Report on Form 10-Q. In certain instances the disclosure schedules to such agreements or documents contain information that modifies, qualifies and creates exceptions to the representations, warranties and covenants. Moreover, some of the representations and warranties may not be complete or accurate as of a particular date because they are subject to a contractual standard of materiality that is different from those generally applicable to stockholders and/or were used for the purpose of allocating risk among the parties rather than establishing certain matters as facts. Accordingly, you should not rely on the representations and warranties as characterizations of the actual state of facts at the time they were made or otherwise.

 

-35-


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

DIODES INCORPORATED

 

 

(Registrant)

 

 

 

 

May 11, 2020

By: /s/ Keh-Shew Lu

 

Date

KEH-SHEW LU

 

 

President and Chief Executive Officer

 

 

(Principal Executive Officer)

 

 

 

 

 

 

 

 

 

 

May 11, 2020

By: /s/ Brett R. Whitmire

  

Date 

BRETT R. WHITMIRE

  

 

Chief Financial Officer

  

 

(Principal Financial Officer)

  

 

 

 

 

-36-